Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Progression of Early Subclinical Atherosclerosis (PESA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Banco Santander
Ministerio de Ciencia e Innovación, Spain
Fundación Botín
Instituto de Salud Carlos III
Fundaciónprocnic
Information provided by (Responsible Party):
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
ClinicalTrials.gov Identifier:
NCT01410318
First received: August 2, 2011
Last updated: July 9, 2014
Last verified: July 2014